Buying medicines can get confusing because the same tablet or syrup is often sold under different names and prices. Medicines ...

Market expert Ankush Bajaj recommends three stocks to buy on 15 December. Discover his exclusive picks and analysis to inform ...

With Qfitlia and Cablivi, Sanofi reaches its fourth and fifth approvals in China this year, following Tzield for stage 2 type ...

Stocks in the news, IPO offerings, IPO listing watchlist, corporate actions and more: your complete guide for the today!

We immediately bristle when we first hear the phrase ‘no other choice’ tossed off early in Park Chan-wook’s contemporary satire “No Other Choice”. The ...

Teva Pharmaceutical is a leader in generic drugs, but these struggling makers of branded drugs may be a better choice.

A California jury on Friday awarded $40 million to two women who said Johnson & Johnson’s baby powder was to blame for their ...

If you are wondering whether NewAmsterdam Pharma still offers good value after its big run, or if you are arriving too late to the party, you are in the right place to explore what the market might be ...

Pre-tax profits at the main Irish arm of pharmaceutical giant Johnson & Johnson declined last year by 35% to €4.47bn.

If you are wondering whether GSK is still good value after its strong run, you are not alone. This article will walk through ...

Pat Kelsey applauded Louisville basketball fans after his team beat Memphis on Saturday. Kelsey had previously pleaded with ...

Many investors may be wondering whether Novartis is still worth considering after its big run, or if most of the potential ...